|
Free Research Articles
Citations 281-290 of 789 total displayed.
|
Past content
(since May 2004):
|
How I treat cobalamin (vitamin B12) deficiency
- Ralph Carmel
Blood 2008; 112: 2214-2221.
[Abstract]
[Full text]
[PDF]
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study
- Harry R. Buller, Anthonie W. A. Lensing, Martin H. Prins, Giancarlo Agnelli, Alexander Cohen, Alexander S. Gallus, Frank Misselwitz, Gary Raskob, Sebastian Schellong, and Annelise Segers, on behalf of the Einstein–DVT Dose-Ranging Study investigators
Blood 2008; 112: 2242-2247.
[Abstract]
[Full text]
[PDF]
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)
- Graham M. Mead, Sharon L. Barrans, Wendi Qian, Jan Walewski, John A. Radford, Max Wolf, Simon M. Clawson, Sally P. Stenning, Claire L. Yule, and Andrew S. Jack, on behalf of the UK National Cancer Research Institute Lymphoma Clinical Studies Group and the Australasian Leukaemia and Lymphoma Group
Blood 2008; 112: 2248-2260.
[Abstract]
[Full text]
[PDF]
Chronic graft-versus-host disease following umbilical cord blood transplantation: retrospective survey involving 1072 patients in Japan
- Hiroto Narimatsu, Shigesaburo Miyakoshi, Takuhiro Yamaguchi, Masahiro Kami, Tomoko Matsumura, Koichiro Yuji, Naoko Murashige, Eiji Kusumi, Yuko Kodama, Tsunehiko Komatsu, Hisashi Sakamaki, Yasushi Kouzai, Masaya Okada, Yuko Osugi, Ryoji Kobayashi, Masami Inoue, Satoshi Takahashi, Shunro Kai, Koji Kato, Tokiko Inoue-Nagamura, Shuichi Taniguchi, and Shunichi Kato, for the Japan Cord Blood Bank Network
Blood 2008; 112: 2579-2582.
[Abstract]
[Full text]
[PDF]
CD4 T cells: fates, functions, and faults
- Jinfang Zhu and William E. Paul
Blood 2008; 112: 1557-1569.
[Abstract]
[Full text]
[PDF]
B lymphocytes: how they develop and function
- Tucker W. LeBien and Thomas F. Tedder
Blood 2008; 112: 1570-1580.
[Abstract]
[Full text]
[PDF]
Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
- Andreas A. Argyriou, Gregoris Iconomou, and Haralabos P. Kalofonos
Blood 2008; 112: 1593-1599.
[Abstract]
[Full text]
[PDF]
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas
- Nancy J. Senff, Evert M. Noordijk, Youn H. Kim, Martine Bagot, Emilio Berti, Lorenzo Cerroni, Reinhard Dummer, Madeleine Duvic, Richard T. Hoppe, Nicola Pimpinelli, Steven T. Rosen, Maarten H. Vermeer, Sean Whittaker, and Rein Willemze
Blood 2008; 112: 1600-1609.
[Abstract]
[Full text]
[PDF]
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
- Stefan Faderl, Farhad Ravandi, Xuelin Huang, Guillermo Garcia-Manero, Alessandra Ferrajoli, Zeev Estrov, Gautam Borthakur, Srdan Verstovsek, Deborah A. Thomas, Monica Kwari, and Hagop M. Kantarjian
Blood 2008; 112: 1638-1645.
[Abstract]
[Full text]
[PDF]
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
- Wendy Stock, Mei La, Ben Sanford, Clara D. Bloomfield, James W. Vardiman, Paul Gaynon, Richard A. Larson, and James Nachman
Blood 2008; 112: 1646-1654.
[Abstract]
[Full text]
[PDF]
|
|
